Apixaban Clinical Trials
21 recruitingDrug
Phase 47Phase 34Not Applicable3Phase 22Early Phase 11Phase 11
Showing 1–20 of 21 trials
Recruiting
Phase 3
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled41 locationsNCT07015905
Recruiting
Phase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Regeneron Pharmaceuticals1,200 enrolled41 locationsNCT07175428
Recruiting
Phase 4
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
CirrhosisAscitesPortal Vein Thrombosis+3 more
Asian Institute Of Medical Sciences220 enrolled1 locationNCT07521332
Recruiting
Phase 4
Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
Staphylococcus Aureus BacteremiaStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia+3 more
McGill University Health Centre/Research Institute of the McGill University Health Centre300 enrolled1 locationNCT06650501
Recruiting
Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation
Nonvalvular Atrial Fibrillation
Bosnalijek D.D800 enrolled1 locationNCT07458191
Recruiting
Phase 1
A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants
Healthy Participants
AstraZeneca186 enrolled2 locationsNCT07312851
Recruiting
Phase 3
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Atrial FibrillationIntracerebral Hemorrhage
Yale University700 enrolled184 locationsNCT03907046
Recruiting
Phase 2
Venous Thromboembolism Prevention in Outpatients With Glioma
GlioblastomaVenous ThromboembolismAstrocytoma
University of Vermont Medical Center40 enrolled1 locationNCT05683808
Recruiting
Phase 3
Thromboprophylaxis in Lower Limb Immobilisation
ThrombosisInjury Leg
Queen Mary University of London10,044 enrolled3 locationsNCT06370273
Recruiting
Not Applicable
Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies
LymphomaLeukemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma+4 more
Medical University of Gdansk100 enrolled1 locationNCT07270263
Recruiting
Phase 4
COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
Atrial Fibrillation
Ottawa Hospital Research Institute3,018 enrolled8 locationsNCT04642430
Recruiting
Phase 4
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
Head and Neck CancerVenous Thromboembolism
Kiranya Arnold76 enrolled1 locationNCT07189897
Recruiting
Not Applicable
Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma
Multiple MyelomaTotal Knee Replacement
Centre Hospitalier Universitaire de Saint Etienne32 enrolled1 locationNCT06474182
Recruiting
Phase 4
Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction
Karolinska Institutet212 enrolled16 locationsNCT06515730
Recruiting
Bariatric Surgery and Pharmacokinetics of Apixaban
Obesity, Morbid
Norwegian University of Science and Technology12 enrolled1 locationNCT03448783
Recruiting
Phase 4
Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
CancerVenous ThromboembolismUpper Extremity Deep Vein Thrombosis+1 more
Ottawa Hospital Research Institute330 enrolled1 locationNCT06603870
Recruiting
Not Applicable
Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury
Spinal Cord InjuriesSpinal Diseases
Loewenstein Hospital60 enrolled1 locationNCT05484557
Recruiting
Phase 4
THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)
Venous ThromboembolismVaricose Veins
Imperial College London6,660 enrolled1 locationNCT05735639
Recruiting
Early Phase 1
Apixaban in Thrombocytopenia
ThrombocytopeniaDeep Vein ThrombosisPulmonary Embolism and Thrombosis+1 more
Rushad Patell30 enrolled1 locationNCT06886516
Recruiting
Pharmacokinetics of Apixaban in Peritoneal Dialysis
Atrial Fibrillation
Chinese University of Hong Kong50 enrolled1 locationNCT05532878